Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
26.46
-0.41 (-1.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
2 Top Biotech Picks to Buy and Hold for the Next 10 Years
↗
May 29, 2021
Incredible scientific advances could reward investors -- if they have the patience.
Via
The Motley Fool
Twist Bioscience Stock Scores Relative Strength Rating Upgrade
↗
May 28, 2021
When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84.
Via
Investor's Business Daily
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
May 25, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Earnings Scheduled For May 6, 2021
↗
May 06, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Twist Bioscience to Present at Upcoming Virtual Conferences
May 25, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics
May 13, 2021
From
Twist Bioscience Corporation
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 10, 2021
Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
64 Biggest Movers From Yesterday
↗
May 11, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....
Via
Benzinga
Barron's Picks And Pans: Hannon Armstrong, Seagate, Tesla, Virtu Financial And More
↗
May 09, 2021
This weekend's Barron's cover story helps investors to prepare for the changes ahead. Other featured articles discuss how to invest in tomorrow's big tech trends,...
Via
Benzinga
What Are the Risks With Twist Bioscience?
↗
May 08, 2021
One especially stands out.
Via
The Motley Fool
Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript
↗
May 07, 2021
TWST earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results
May 06, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Why Does Cathie Wood Like This Healthcare Stock So Much?
↗
May 06, 2021
Twist Bioscience brings to mind another genomic revolution pioneer.
Via
The Motley Fool
3 Exciting Biotech Stocks to Buy Right Now
↗
April 30, 2021
Gene therapies could be poised to enter an era of extraordinarily rapid advancement.
Via
The Motley Fool
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
↗
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
April 28, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021
April 22, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Expand Oregon Lease, Supporting Future Growth
April 16, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities
April 14, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021
↗
April 12, 2021
Upgrades For Eni SpA (NYSE:E), Credit Suisse upgraded the previous rating of Underperform to Neutral. For the fourth quarter, Eni had an EPS of $0.02, compared to year-ago...
Via
Benzinga
Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software
April 12, 2021
From
Twist Bioscience
Via
Business Wire
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
↗
April 09, 2021
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg...
Via
Benzinga
AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
April 07, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories
April 07, 2021
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today